- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03974659
Enhanced Recovery After Surgery Using TMS on Cerebellar Language Area for Brain Tumor Patients
Through the Navigation Transcranial Magnetic Stimulation Over the Language Key Areas of Cerebellar to Enhance Language Function Recovery After Brain Tumor Resection
At present, the incidence of language dysfunction in patients with brain language area tumor in the first month after operation was 20%-40%. The investigator's team has confirmed and found that bilateral cerebellar VIIa lobules are the critical areas of cerebellar which is closely related to the language function of the patients. This study aims at enhancing language function recovery after surgery through the transcranial magnetic stimulation stimulates the key areas of cerebellar.
This study is a prospective, randomized, double-blind, multi-center clinical trial in which participants with postoperative aphasia in the brain-language region tumors of three neurosurgery departments, Huashan Hospital, Shanghai Jing'an Center Hospital and Huashan Hospital North Hospital. Participants were randomly divided into Intervention group and control group. Before transcranial magnetic stimulation treatment, the two groups were required to conduct language behavior assessment and magnetic resonance imaging data. Participants in both groups were given 10 consecutive days bilateral cerebellar VIIa lobules Theta Burst Stimulation from one week after surgery and received speech rehabilitation training after stimulation.
The investigators collect patients MRI data and language behavioral assessment scores at 1week post operation and 1 month after the operation and 3 months after the operation. Subsequently, three MRI data and language behavioral assessment scores were processed and statistically analyzed to compare the differences between the two groups
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Intervention group: Intermittent Theta Burst Stimulation(Positive stimulation) is used in right cerebellar VIIa lobule. Continuous Theta Burst Stimulation(Negative stimulation) is used in left cerebellar VIIa lobule. The stimulation intensity was 80% Rest Motor Threshold.According to the patients' condition, age and tolerance,the intensity should be adjusted.
Control group: The investigators use with fake stimulation , the appearance is the same as the magnetic stimulator used in the experimental group, and the stimulation will also make sounds, but no magnetic field effect, the stimulation mode is the same as the intervention group.
Subsequently, The investigators collect patients MRI data and language behavioral assessment scores at 1week post operation and 1 month after the operation and 3 months after the operation.three times MRI data and language behavioral assessment scores were processed and statistically analyzed to compare the differences between the two groups from the cerebellar spontaneous neurological activity level (ALFF), cerebellar gray matter volume, functional connectivity of cerebellar network and language behavioral score.
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Shanghai
-
Shanghai, Shanghai, Kina, 200040
- Rekruttering
- Huashan Hospital Affiliated to Fudan University
-
Ta kontakt med:
- Jinsong Wu, MD
- Telefonnummer: 86-021-52887200
- E-post: wjsongc@126.com
-
Hovedetterforsker:
- Jinsong Wu, MD
-
Underetterforsker:
- Dongxiao Zhuang, MD
-
Underetterforsker:
- Tianming Qiu, MD
-
Underetterforsker:
- Jie Zhang, MD
-
Ta kontakt med:
- Tianming Qiu, MD
- Telefonnummer: 86-021-52887200
- E-post: Tianming2100@126.com
-
Underetterforsker:
- ruiping Hu, MD
-
Underetterforsker:
- Qiao Shan, MD
-
Underetterforsker:
- Chengxin Ma, MD
-
Shanghai, Shanghai, Kina, 200040
- Rekruttering
- Shanghai Jing'an Central Hospital
-
Ta kontakt med:
- Qingyang Luo, MD
- Telefonnummer: 021-61578000
- E-post: luoqingyang529@sina.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Language dysfunction after brain tumor surgery (aphasia quotient,AQ)< 93.8
- Chinese mother tongue
- Right handedness confirmed by Edinburgh Handedness Scale
- Tumor patients with linguistic region involvement in the dominant hemisphere
- Karnofsky Performance Status (KPS)< 70
- Voluntary participation in this project
Exclusion Criteria:
- Patients with frequent epileptic seizures (> 2 epilepsy episodes per week)
- Previous implants of metal pacemakers, stimulators, hearing aids, dentures, and insulin pumps or claustrophobia
- People with a history of psychiatric disorders
- Patients with severe medical diseases
- Patients with Alzheimer's disease and Parkinson's disease. Medical diseases
- Pregnant women
- Other clinical trials in the same period.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Theta Burst Stimulation
Intervention group: ten consecutive days bilateral cerebellar VIIa lobules Theta Burst Stimulation. Intermittent Theta Burst Stimulation(Positive stimulation) is used in right cerebellar VIIa lobule.Each stimulus had three 50 Hz monopulses, which were repeated every 200 ms. Each stimulation continued for 2 seconds and rested for 8 seconds. The total intervention time was 200s (600 pulses) Continuous Theta Burst Stimulation(Negative stimulation) is used in left cerebellar VIIa lobule,three 50 Hz monopulses in each stimulus, each with an interval of 200 ms, and each intervention lasted 40s (600 pulses). The stimulation intensity was 80% Rest Motor Threshold.According to the patients' condition, age and tolerance,the intensity should be adjusted. |
1.Patients were given 10 consecutive days bilateral cerebellar VIIa lobules Theta Burst Stimulation which was a special mode of Transcranial magnetic stimulation from one week after surgery Intermittent Theta Burst Stimulation(Positive stimulation) is used in right cerebellar VIIa lobule.Each stimulus had three 50 Hz monopulses, which were repeated every 200 ms.
Each stimulation continued for 2 seconds and rested for 8 seconds.
The total intervention time was 200s (600 pulses) Continuous Theta Burst Stimulation(Negative stimulation) is used in left cerebellar VIIa lobule,three 50 Hz monopulses in each stimulus, each with an interval of 200 ms, and each intervention lasted 40s (600 pulses).
Andre navn:
|
|
Sham-komparator: sham Theta Burst Stimulation
sham group: we flip coil to make fake stimulation, the stimulation will also make sounds, but no magnetic field effect, the stimulation mode is the same as the intervention group.
|
1.Patients were given 10 consecutive days bilateral cerebellar VIIa lobules Theta Burst Stimulation which was a special mode of Transcranial magnetic stimulation from one week after surgery Intermittent Theta Burst Stimulation(Positive stimulation) is used in right cerebellar VIIa lobule.Each stimulus had three 50 Hz monopulses, which were repeated every 200 ms.
Each stimulation continued for 2 seconds and rested for 8 seconds.
The total intervention time was 200s (600 pulses) Continuous Theta Burst Stimulation(Negative stimulation) is used in left cerebellar VIIa lobule,three 50 Hz monopulses in each stimulus, each with an interval of 200 ms, and each intervention lasted 40s (600 pulses).
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Boston naming test
Tidsramme: Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
The change of Boston naming test scores is being assessed
|
Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
|
MMSE
Tidsramme: Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
The change of Mini-mental State Examination scores is being assessed
|
Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
|
ABC
Tidsramme: Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
Aphasia Battery of Chinese,Conclude naming, repeating, comprehend and spontaneous speech test,The change of ABC scores is being assessed
|
Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
|
ALFF
Tidsramme: Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
The change of Cerebellar spontaneous neurological activity level is being assessed
|
Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
|
Cerebellar gray matter volume
Tidsramme: Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
The change of Cerebellar gray matter volume is being assessed
|
Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
|
Functional connectivity of cerebellar network
Tidsramme: Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
The change of functional connectivity of cerebellar network is being assessed
|
Change from postoperative 1 week to postoperative 1month & postoperative 3 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Jinsong Wu, MD, Huashan Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- KY2018-395
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .